Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

Free COVID-19 Test Kits To Be Available Again

The new kits were supposed to be available for order on Monday

International Business Times · Sep 23, 2024

New Migraine Drugs No Better Than Cheap Painkillers: Big Study

Migraine drugs can represent big money for pharmaceutical firms, as shown when Pfizer acquired Biohaven -- which developed rimegepant -- for more than $10 billion in 2022.

Latin Times · Sep 19, 2024

Will the XEC COVID subvariant bring a fall wave of infections? What to know about symptoms and spread

The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.

Fortune · Sep 18, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Covid conspiracy theorist convicted of terrorism after Telegram calls for vaccine violence

Patrick Ruane, 55, from Paddington, west London, weaponised social media app Telegram to encourage attacks

Evening Standard · Sep 13, 2024

New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots

COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it’s estimated COVID shots have saved more than 1.4 million lives in the World Health Organization’s (WHO) European region alone since their introduction in December 2020.

The Conversation · Sep 9, 2024

A mural honoring scientists hung in Pfizer's NYC lobby for 60 years. Now it's up for grabs

A New York City mural honoring ancient and modern figures in medicine could end up in pieces if it can’t find a new patron soon

The Independent UK · Sep 7, 2024

You Can Stop Looking, Here's the Perfect Stock for the Current Market

While technology stocks continue to struggle, stocks in the lucrative over-the-counter healthcare products sector are thriving. One prominent such name is Haleon. Its stock has jumped more than 22% over the past three months, as sales and profits in its nine large-scale multinational, high-margin 'power brands' continue to hold leading…

Barchart · Sep 4, 2024

Read news from The Economist, FT, and more,
with one subscription

Is Pfizer Stock Underperforming the Dow?

Although Pfizer underperformed the Dow Jones this year, analysts are moderately bullish on the stock’s prospects.

Barchart · Sep 4, 2024

COVID-19, flu and RSV shots − an epidemiologist explains why all three matter this fall

The Food and Drug Administration approved and granted emergency use authorization on Aug. 22, 2024, for the newest, updated version of the COVID-19 vaccine. The Centers for Disease Control and Prevention quickly endorsed the new shot to protect against severe illness.

The Conversation · Aug 30, 2024

New COVID vaccines are here. What to know about 2024–25 shots as summer surge continues

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.

Fortune · Aug 29, 2024

When is Canada launching new Covid vaccines targeting KP.2 variant? All you want to know

Close on the heels of US approving vaccines to fight KP.2 variant of Omicron, Health Canada has said they are reviewing updated vaccines that target the strain currently in circulation. The health regulator has said the review process will be completed by early autumn, post which the vaccines will be…

The Times of India · Aug 28, 2024

A new Covid vaccine is available. Here’s why some people might not want it right away

Updated Covid vaccines were approved by the FDA earlier this month

The Independent UK · Aug 27, 2024

FDA Approves Updated Covid-19 Vaccines From Moderna And Pfizer

FDA approves updated Covid-19 vaccines from Moderna and Pfizer/BioNTech to enhance protection against current variants and combat rising cases.

New Covid vaccines targeting KP.2 variant approved; 5 things to know

As the summer wave, dominated by FlirT variants, takes over the United States, The Food and Drug Administration has approved updated Covid-19 vaccines that specifically target recent variant of the disease - KP.2.

The Times of India · Aug 23, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Aug 23, 2024

Updated COVID mRNA Vaccines Get FDA Approval: Here's What To Know

The updated COVID shots from Pfizer-BioNTech and Moderna target the current KP.2 strain of SARS-CoV-2, a descendant of the highly contagious Omicron subvariant JN.1.

Barchart · Aug 22, 2024

3 High-Yield S&P 500 Stocks to Buy and Hold

Three high-yield S&P 500 stocks, Devon Energy, Verizon Communications, and Pfizer Inc., are poised to provide a balanced mix of income and growth, making them attractive options for long-term investors.

Salon · Aug 22, 2024

New COVID vaccines approved early

New shots from Pfizer and Moderna will be available within days. Here's how to get yours

FDA Approves Updated COVID-19 Vaccines Targeting Variants

FDA-approved updated COVID-19 vaccines crucial for protection against new strains. Get vaccinated promptly to safeguard public health.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Aug 22, 2024

FDA approves updated COVID-19 vaccines, shots should be available in days

Updated COVID-19 vaccines are on their way

Roll Call · Aug 22, 2024

FDA greenlights updated COVID shots, prepares for fall rollout - Roll Call

The FDA approved updated COVID-19 vaccines for the 2024-25 season, preparing for an expected spike in cases this fall and winter.

Barchart · Aug 20, 2024

Dividend Stocks At Risk: Is Your Income Strategy Safe?

At least three high-yield stocks have suspended their dividend payments over the last month. Here are a few other stocks whose dividends could be at risk, according to Piper Sandler's analysis.

Pfizer's Dividend Yield Surpasses 6% Mark, Attracting Investors

Learn about the role of dividends in stock market returns and the significance of sustainable yields, using Pfizer as an example.

The Independent UK · Aug 12, 2024

Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatments

Pfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world

Barchart · Aug 6, 2024

2 Dividend Stocks to Buy in August If the Market Crash Scares You

Volatility is back on Wall Street, which is bound to scare some investors. Meanwhile, Pfizer and Starbucks are two high dividend names with limited downside which conservative investors can consider now.

LiveScience · Aug 6, 2024

CDC issues new guidelines for RSV vaccines, citing side-effect concerns

The CDC has clarified and narrowed its recommendations for which older adults should get an RSV vaccine.

1 … 16 17 18 19

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Food and Drug Administration

593 stories

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.